Only about 6% of the world’s population are native English speakers, and 75% of people don’t speak English at all. Many people do not have access to high-quality health information, because it is not available in a language that they understand. We translate Cochrane evidence to make it more accessible, and to reduce the linguistic barrier to...

Global leaders in evidence-based healthcare highlight the urgent need to advance global health equity Cochrane has partnered with JBI, Campbell Collaboration, GIN, the Institute for Evidence-Based Healthcare, the Centre for Evidence-based Health Care and NICE to launch the 2023 campaign for World Evidence-Based Healthcare (EBHC) Day, called ‘...

Cochrane France is dedicated to promoting evidence-informed decision-making and practice. To support this mission, Cochrane France has launched a new project, Cochrane Clinical Vignettes. Cochrane France intends to produce several clinical vignettes per year covering various medical specialties in collaboration with Cochrane Skin, Cochrane Lung...

Cochrane, a global independent network of researchers, professionals, patients, carers, and health enthusiasts is celebrating our 30th anniversary in 2023. In 1987, the year before Archie Cochrane died, he referred to a systematic review of randomized controlled trials of care during pregnancy and childbirth as "a real milestone in the history of...

Key Points  Comprehensive study reveals nicotine e-cigarettes, varenicline and cytisine are the stop-smoking aids most likely to help people quit smoking. On average, for every 100 people trying to quit, around 14 are likely to succeed using an e-cigarette, varenicline or cytisine in any given quit attempt. This is compared to 6 in 100 who are...